TTE Improves Clinical Management of Stable Chest Pain
Recruiting now
Conditions studied: Transthorcic Echocardiography, Stable Angina Pectoris, Coronary Artery Disease, Major Adverse Cardiac Events, Invasive Coronary Angiography
In brief
The investigator aims to prospectively enroll patients who were referred for transthorcic echocardiography (TTE) for the assessment of stable chest pain (SCP) suspected of obstructive coronary artery disease (CAD). All patients underwent TTE according to established guidelines and local institutional protocols. This study will determine if TTE-based imaging evaluation can provide more informaton to improve clinical management for SCP, including fewer MACE and better decision-making of downstream investigations and therapeutic interventions.
Key facts
- Study ID
- NCT07063147
- Run by
- Tianjin Chest Hospital
- People needed
- 50000
- Starts
- 2025-01-01
- Expected to finish
- 2040-12-31
- Last updated by the study team
- 2025-07-18
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- symptomatic patients with SCP suspected of obstructive CAD.
- referred for TTE for the assessment of SCP.
- ≥18 years of age.
- signed informed consent.
You may not qualify if…
- acute coronary syndromes
- previous CAD or coronary revascularization
- nonsinus rhythm
- cardiomyopathy, valvular disease, congenital heart disease or left cardiac insufficiency because of other reasons
Where it is running
- Tianjin Chest Hospital — Tianjin, China (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.